 |
|
Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures
The Division of Chemical, Biological, Radiological and Nuclear (CBRN) Medical Countermeasures (MCMs) develops and procures the CBRN MCMs required by the U.S. Department of Health and Human Services (HHS) to mitigate the adverse health effects arising from public health emergencies. Learn More >> |
 |
|
Influenza Division
The National Strategy for Pandemic Influenza (November 2005) designated the Department of Health and Human Services (HHS) as the lead agency for public health preparedness and medical response to a probable or actual influenza pandemic. Learn More >> |
 |
|
Division of Regulatory & Quality Affairs
The Division of Regulatory & Quality Affairs (RQA) develops strategies to facilitate the regulatory development pathway and to anticipate product lifecycle issues. It applies quality and regulatory best practices to the life cycle management of MCMs ultimately needed for stockpiling, delivery, and use. Learn More >> |
 |
|
Strategic Science and Technology
The Division of Strategic Science and Technology (SST) identifies and supports the advancement of platform technologies that enhance capabilities for the development and manufacturing of medical countermeasures (MCMs). Learn More >> |